Through our collaboration with Tulane University and other academic, research and industry partners in the Viral Hemorrhagic Fever Consortium, we are developing numerous diagnostic products for detecting biological agents. These products will not only be valuable in clinical testing situations worldwide, but will be important additions to our nation’s defense against bio-threat agents.
We are currently developing diagnostic products to detect the Lassa virus (LASV), Junin virus (JUNV), Ebola virus (EBOV) and Marburg virus (MARV), all very important pathogens. Through our consortium we are also in early development of additional products for Dengue virus (DENV), Chikungunya virus (CHIKV), Crimean-Congo virus (CCHV) and others.
Our infectious disease products will be used not only in clinical laboratories but also in point-of-care testing in the field.
The first of these products to be completed is the Rapid Test for detection of Lassa hemorrhagic fever. It is in final clinical studies and will be submitted to the FDA in 2012.
Learn more about our Infectious Disease Products by visiting the Viral Hemorrhagic Fever Consortium website at www.vhfc.org.